Getting your patients started with NUEDEXTA®

RECOMMENDED DOSAGE AND ADMINISTRATION

  • Starting dose: One capsule daily by mouth for 7 days 
  • Maintenance dose: After 7 days, 1 capsule every 12 hours

 

NUEDEXTA does not belong to the class of antipsychotic medications40

As a treatment for PBA, NUEDEXTA is not characterized as a psychopharmacologic agent; it is classified as a “Central Nervous System Agent, Other” per the USP model formulary.40

    Titrate from QD to Q12H on Day 831

    Days 1-7

    1 capsule QD

    DMQ20-10
    Beginning Day 8

    1 capsule Q12H

    DMQ20-10DMQ20-10

    Recommended prescribing of NUEDEXTA therapy32

    SPECIFIC POPULATIONS31

    No dose adjustments are required in patients with mild to moderate renal or hepatic impairment. NUEDEXTA has not been evaluated in patients with severe renal or hepatic impairment.

    Accurately document your PBA diagnosis—ICD-10 code F48.2—to comply with CMS standards.a,22

     

    Ordering NUEDEXTA in long-term care

    Script pad is for illustration purposes only and
    represents prescription for maintenance therapy
    after initial-week titration period with QD dosing.

    aICD-10-CM codes submitted to the payer must be determined by the provider/physician and accurately describe the diagnosis for which the patient receives NUEDEXTA treatment, represent codes at the highest level of specificity and reflect the contents of any clinical notes and/or chart documentation. The coding information contained herein is gathered from various resources and is subject to change. Nothing in this document is intended to serve as reimbursement advice, a guarantee of coverage, or a guarantee of payment for NUEDEXTA. Please refer to your payer plans for specific guidance.